A University of Toronto Engineering research team has created a new platform that delivers multiple therapeutic proteins to the body, each at its own independently controlled rate. The innovation could help treat degenerative diseases such as age-related macular degeneration (AMD), the leading cause of vision loss for people over 50.
Click here for original story, New strategy for delivery of therapeutic proteins could help treat degenerative eye diseases
Source: Phys.org